During controlled clinical trials in healthy subjects, single doses of up to 800 mg empagliflozin, were well tolerated.
Treatment: In the event of an overdose, supportive treatment should be initiated as appropriate to the patient's clinical status. The removal of empagliflozin by haemodialysis has not been studied.